Premium
Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al
Author(s) -
Curtis Jeffrey R.,
Wright Grace C.,
Strand Vibeke,
Davis Charles S.,
Hitraya Elena,
Sasso Eric H.
Publication year - 2017
Publication title -
arthritis and rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.106
H-Index - 314
eISSN - 2326-5205
pISSN - 2326-5191
DOI - 10.1002/art.39981
Subject(s) - abatacept , adalimumab , rheumatoid arthritis , medicine , methotrexate , biomarker , oncology , disease , rituximab , biochemistry , chemistry , lymphoma